secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2022-11-29T23:59:59+00:00
Accession:  0001104659-22-122661
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie CFO promoted to EVP; Controller Durkin to retire, Buckbee named successor
--------------------------------------------------------------------------------

- Scott T. Reents, previously Senior VP/CFO, appointed Executive Vice President, CFO effective immediately.
- Brian L. Durkin, VP Controller, plans to retire effective March 1, 2023.
- Kevin K. Buckbee, 57, appointed Senior VP Controller effective March 1, 2023; previously VP Controller, Global Commercial Ops since Jan 2016.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/tm2231449d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-122661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer